Catalyst

Slingshot members are tracking this event:

Aralez (ARLZ) Granted U.S Patent Covering Yosprala, the Only Fixed Dose Combination of Aspirin and Omeprazole

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ARLZ

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 11, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords U.s Patent, United States Patent And Trademark Office, Uspto, Yosprala, Aspirin, Omeprazole